日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study

古塞库单抗和乌司奴单抗治疗银屑病患者的疗效、安全性和生活质量影响:来自德国PERSIST非干预性、前瞻性多中心研究的第104周结果

Gerdes, S; Hoffmann, M; Asadullah, K; Korge, B; Mortazawi, D; Krüger, N; Personke, Y; Tabori, S; Gomez, M; Wegner, S; Kreimendahl, F; Taut, F; Sticherling, M

Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

对新型选择性糖皮质激素受体激动剂 ZK 245186 进行表征,用于局部治疗炎症性皮肤病

Schäcke H, Zollner T M, Döcke W D, Rehwinkel H, Jaroch S, Skuballa W, Neuhaus R, May E, Zügel U, Asadullah K

Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type

长期存在白细胞介素-10可诱导一种新型单核细胞衍生细胞类型的发育。

Schoenbein, C; Docke, W-D; Wolk, K; Belbe, G; Hoflich, C; Jung, M; Grutz, G; Sterry, W; Volk, H-D; Asadullah, K; Sabat, R

IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach

IL-10是银屑病中的关键细胞因子。IL-10疗法原理验证:一种新的治疗方法

Asadullah, K; Sterry, W; Stephanek, K; Jasulaitis, D; Leupold, M; Audring, H; Volk, H D; Döcke, W D